Marché mondial des agonistes des récepteurs opioïdes MU – Tendances et prévisions de l'industrie jusqu'en 2028

Analyse et perspectives du marché : Marché mondial des agonistes des récepteurs opioïdes MU

Le marché mondial des agonistes des récepteurs opioïdes MU devrait connaître une croissance exponentielle au cours de la période de prévision de 2021 à 2028. Data Bridge Market Research analyse que le marché croît à un TCAC sain au cours de la période de prévision de recherche mentionnée ci-dessus. La prévalence croissante de la douleur intense et de la toxicomanie dans le monde et sur les marchés émergents sont les facteurs responsables de la croissance de ce marché.

L'augmentation des cas de douleurs sévères liées à la maladie stimule le marché mondial des agonistes des récepteurs mu aux opioïdes. L'adaptation à un mode de vie malsain et à des maladies provoquant des douleurs sévères telles que le cancer , la fibromyalgie et l'arthrite, qui augmentent le risque d'évolution de la douleur, stimule également la croissance du marché mondial des agonistes des récepteurs mu aux opioïdes. En outre, la disponibilité du traitement assiste également à la croissance de ce marché. La prévalence accrue de la toxicomanie et des douleurs sévères, les programmes de sensibilisation du gouvernement auprès de la population, qui sont reconnus comme moteurs du marché mondial des agonistes des récepteurs mu aux opioïdes. Cependant, le nombre important de décès par abus de drogues et les directives spécifiques de la FDA pour la fabrication et la vente de produits contenant des opioïdes peuvent entraver la croissance du marché mondial des agonistes des récepteurs mu aux opioïdes.

Les agonistes des récepteurs mu opioïdes sont considérés comme les agents analgésiques les plus puissants. Ils produisent un effet analgésique en se liant au site récepteur Mu d'abord dans le cerveau, puis dans la corne dorsale de la moelle épinière. Ils peuvent être utilisés pour divers types de gestion de la douleur à faible dose. Cependant, ils présentent également certains inconvénients tels que la récompense/euphorie, la sédation, la dépression respiratoire, les vomissements, les nausées, etc., qui limiteront le traitement de la douleur aux opioïdes.

This opioid MU receptor agonist market provides details of market share, new developments and product pipeline analysis, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions and technological innovations in the market. To understand the analysis and the market scenario contact us for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.

Global Opioid MU Receptor Agonist Market Scope and Market Size

The opioid MU receptor agonist market is segmented on the basis of application, drugs, route of administration, end users, distribution channel. The growth among segments helps you analyse niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

• On the basis of application, the opioid MU receptor agonist market is segmented into pain management, cough management, diarrhea suppression, anesthesia, de-addiction and others.
• On the basis of drugs, the opioid MU receptor agonist market is segmented into IR/short acting, ER/long acting and others.
• On the basis of route of administration, the opioid MU receptor agonist market is segmented into oral, parenteral and others.
• On the basis of end users, the opioid MU receptor agonist market is segmented into hospitals, specialty clinics and others.
• On the basis of distribution channel, the opioid MU receptor agonist market has also been segmented into hospital pharmacy, retail pharmacy others.

Opioid MU Receptor Agonist Market Country Level Analysis

Global opioid MU receptor agonist market is analyzed and market size information is provided by country, application, drugs, route of administration, end users and distribution channel as referenced above.

The countries covered in the opioid mu receptor agonist market report are U.S., Canada, Mexico in North America, Brazil, Argentina, Peru, Rest of South America, as part of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, in the Asia-Pacific, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa, as a part of Middle East and Africa.

North America dominates the market share due to increasing healthcare and R&D expenditure, patient awareness and global players on novel technology or formulation of existing drugs plays major role for the growth of opioid mu receptor agonist market. Asia-Pacific is expected to account for the largest market share over coming years for the opioid mu receptor agonist market due to high prevalence cases diabetes and related disorders and number of generic drugs while, Europe is considered to hold bright growth prospects in the coming years by expanding the expenditure on the healthcare sector.

The country section of the report also provides individual market impacting factors and changes in regulations in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

Patient Epidemiology Analysis

This opioid MU receptor agonist market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to market growth are analyzed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.

Competitive Landscape and Opioid MU Receptor Agonist Market Share Analysis

Global opioid MU receptor agonist market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to opioid MU receptor agonist market.

Les concurrents du marché qui travaillent actuellement sur le marché des agonistes des récepteurs opioïdes MU sont US WorldMeds, LLC. Hikma Pharmaceuticals PLC, ALLERGAN, Piramal Critical Care, DAIICHI SANKYO COMPANY, LIMITED., SPECGX LLC, Janssen Pharmaceuticals, Inc., Teva Pharmaceutical Industries Ltd., Pfizer Inc., Mylan NV, Purdue Pharma LP, WraSer LLC., Lannett, Virtus, Sentynl Therapeutics, Inc., Sun Pharmaceutical Industries Ltd., Cipher Pharmaceuticals Inc. et d'autres acteurs nationaux et mondiaux. Les analystes de DBMR comprennent les atouts de la concurrence et fournissent une analyse concurrentielle pour chaque concurrent séparément.

SKU-60380